CSMD2 and neoplasm: Reduced CSMD2 expression was linked to tumour size, lymphatic invasion, and differentiation in colon cancer, the development of pulmonary sarcomatoid carcinoma, liver metastasis, and pancreatic cancer [17,18,19,20].